Reneo Pharmaceuticals Inc., which announced in December the failure of its drug to treat rare genetic diseases, said it will be acquired by OnKure Inc., a Boulder, Colo.-based privately held biopharmaceutical company.
Life Sciences Hedge Fund Perceptive Preps a New SPAC institutionalinvestor.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from institutionalinvestor.com Daily Mail and Mail on Sunday newspapers.
AltruBio Secures up to $225M Oversubscribed Series B Financing to Advance the Clinical Development of Novel Immune Checkpoint Enhancer Program tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.